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Abstract 
Aims: Psychosocial factors are rarely collected in studies investigating the prognosis of patients 
with heart failure (HF), and only time to first-event is commonly reported. We investigated the 
prognostic value of psychosocial factors for predicting first or recurrent events after discharge 
following hospitalization for HF.  
Methods and results: OPERA-HF is an observational study enrolling patients hospitalized for 
HF. In addition to clinical variables, psychosocial variables are recorded. Patients provide the 
information through questionnaires which include social information, depression and anxiety 
scores, and cognitive function. Kaplan-Meier, Cox regression and the Andersen-Gill model were 
used to identify predictors of first and recurrent events (re-admissions or death).  
Of 671 patients (age 76±15 years, 66% men) with one-year follow-up, 291 had no subsequent 
event, 34 died without being readmitted, 346 had one or more unplanned readmissions and 71 
patients died after a first readmission. Increasing age, higher urea and creatinine, the presence of 
co-morbidities (diabetes, history of MI, COPD), were all associated with increasing risk of first 
or recurrent event. Psychosocial variables independently associated with both the first and 
recurrent events were: presence of frailty, moderate to severe depression and moderate to severe 
anxiety. Living alone and the presence of cognitive impairment were independently associated 
only with an increasing risk of recurrent events.  
Conclusion: Psychosocial factors are strongly associated with unplanned recurrent readmissions 
or mortality following an admission to hospital for HF. Further research is needed to show 
whether recognition of these factors and support tailored to individual patients’ needs will 
improve outcomes. 
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1. Introduction 
Patients with heart failure (HF) are at high risk of readmissions and death. About 25% of 
patients admitted with HF are readmitted within one month of leaving hospital.1 In European 
studies, the readmission rate is up to 44% at 1 year after discharge.1 Commonly, studies 
investigating risk factors for readmission only consider the first readmission. However, they are 
often recurrent, reflecting progression of the underlying disease or exacerbations due to co-
morbidities and sub-optimal self-care and medication adherence. Understanding the causes, 
precipitants and risk factors for recurrent readmissions may help to prevent them. By focusing 
only on first event analysis, any subsequent events are ignored and the impact of potential risk 
factors can be greatly under- or over- estimated. 
 Several demographic or clinical variables, such as age, sex, the presence of co-
morbidities, left ventricular ejection fraction, New York Heart Association class of symptoms 
and serum markers are important predictors of readmissions and death among patients with HF.2 
The impact of psychosocial factors on first readmission or mortality has also been studied. 3 The 
presence of some psychosocial factors, such as depression, are significant predictors of mortality 
among patients with HF.4,5 The presence of frailty is also associated with increasing risk of first 
readmission or mortality.6,7 However, there is no report about the effect of depression, frailty and 
other psychosocial factors on recurrent events.  
Accordingly, we explored the effect of psychosocial factors on first and recurrent 
unplanned readmissions or death in a cohort of patients discharged after a hospitalization for 
worsening HF. 
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2. Methods 
2.1. Study design 
OPERA-HF is an ongoing prospective observational study, enrolling patients hospitalized 
for HF in the Hull & East Yorkshire Hospitals NHS Trust, UK. The aim of the study is to create 
a holistic view of the patients, their general condition and co-morbidities, and to identify 
predictors of mortality and re-admission to hospital. Additional assessments, including 
assessments of depression/anxiety and cognitive function, were performed during hospital 
admission using questionnaires completed by the patient.  
Patients had to fulfill all of the following criteria to be included in the present study: age 
>18 years; usual residence in the region served by the Hull & East Yorkshire Hospitals Trust; 
hospitalization for HF; treatment with loop diuretics; and at least one of the following: left 
ventricular ejection fraction (LVEF) ≤ 40%, left atrial dimension >4.0 cm 8 or NT-ProBNP >400 
pg/ml (if in sinus rhythm) or >1200 pg/ml (if in atrial fibrillation). 9 Patients who were unable to 
understand and comply with the protocol or unable or unwilling to give informed consent were 
not included in the study. The study has full ethical approval from the South Yorkshire Research 
Ethics Committee (REC ref: 12/YH/0344) and is conducted in accordance with ICH-GCP, 
Declaration of Helsinki, the Data Protection Act 1998 and the NHS Act 2006.  
2.1.1. Depression and anxiety assessment 
Depression and anxiety were assessed by the Hospital Anxiety and Depression Scale 
(HADS) questionnaire.10 The HADS consists of two parts of 7 questions each, one focusing on 
depression and one on anxiety. For each part, the response to each of the 7 questions is graded 
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from 0 to 3, giving a total score that ranges between 0 and 21. A score of 7 or less implies that 
there is no depression or anxiety; a score of 8-10 suggests mild depression or anxiety; and a 
score of 11 or more reflects moderate-to-severe depression or anxiety. 10  
2.1.2. Cognition assessment 
This assessment was based on the General Practitioner assessment of Cognition 
(GPCOG),11 a brief screening tool for detecting cognitive impairment. It was designed for use by 
primary care practitioners. The cognitive test includes nine items focusing on time orientation, 
clock drawing, awareness of a current news event and recall of a name and an address. Each 
correct answer scores one point leading to a maximum score of 9. A score of 4 or lower indicates 
cognitive impairment.  
2.1.3. Frailty 
For frailty, a two-fold assessment was applied. First the patient was asked to respond to a 
question about having troubles bathing or dressing and then was assessed through the ‘get up and 
go’ test. The timed ‘get up and go’ requires patients to stand up from a chair, walk a short 
distance (3 m), turn around, return, and sit down again. The normal time to complete the task is 
less than 10 seconds and abnormal is more than 20 seconds.12 Patients who reported either 
troubles in bathing or dressing or completed the ‘get up and go’ test in more than 20 seconds 
were defined as frail.  
2.1.4. Readmission/Mortality 
All patients enrolled in the study are followed subsequent to discharge. All-cause 
readmissions and mortality are automatically recorded in the hospital’s IT system. For the 
present report, the primary outcome of interest was all-cause unplanned readmissions or 
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mortality. Unplanned readmission is considered any type of emergency readmission such as 
emergency fast-track, through the Accident and Emergency department, or an urgent admission 
requested by the GP.  
2.2. Statistical analysis 
We report the baseline characteristics of the patients who participated in the study 
between 14/10/2012 and 30/07/2016. Follow up was censored at 22/08/2016. We describe and 
compare the baseline characteristics of the patients by the number of their subsequent events. For 
the comparison among patients having no event with patients having one or multiple 
readmissions or death after discharge, we used the chi-squared test to compare binary or 
categorical variables, and Kruskal-Wallis test for continuous variables. In order to avoid 
comparisons between groups of patients with unequal follow up times, we initially analysed 
events in patients for whom one year follow up data were available, including only those events 
which happened in the first year, in order to compare those with and those without an event.  
We subsequently included all patients in statistical modeling to determine the relation 
between a putative risk factor and outcome. The Kaplan-Meier method was used to estimate the 
cumulative incidence of events (readmissions and mortality).13 The event rate was calculated by 
taking into account all available recurrent events. We used univariable Cox regression to 
calculate the effect of potential risk factors on the first unplanned readmissions or death. The 
Andersen-Gill model was used to analyze the effect of the same factors when taking into account 
recurrent unplanned readmissions or death. The counting processes model of Andersen-Gill is a 
semiparametric model, and is a generalization of the Cox regression model.14 It takes into 
account all the recurrent events along the time line, where the time to an event starts at the end of 
the previous event. All events are treated as being similar and independent of each other. 
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After identifying predictors of outcome, we calculated the effect of each psychosocial 
variable whilst adjusting for all significant clinical ones. For the psychosocial variables we used 
only complete cases and for clinical variables we used multiple imputation to impute missing 
values. 15 Application of the technique requires three steps: imputation, analysis and pooling. 
Each missing clinical value was imputed 5 times following the predictive mean matching 
method, thus producing 5 imputed data sets; each one of these 5 imputed data sets was then 
analyzed by the aforementioned complete-data procedures. The 5 resulting analyses are then 
combined into one final analysis following Rubin’s method. The means of these pools are 
reported in the result section.15,16 All analyses were conducted using R 3.3.2 statistical software 
(The R Foundation for Statistical Computing, Vienna, Austria).   
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3. Results  
 Of 814 patients consented, 35 died during the index admission and 779 were discharged. 
(Consort diagram: Figure 1) The median follow up amongst survivors was 764 (interquartile 
range, IQR 411–1069) days. 671 patients either died during the first year or were still alive at 
one year. The remaining 108 patients were survivors who had not yet completed their first year 
follow up after discharge.  
 Figure 1 
3.1. First year follow up 
 Figure 2a shows the outcomes at one year for the 671 patients who had at least one year 
follow-up or who died within one year and consequently had known one year outcome. During 
the first year, 291 (43%) patients had no event; 34 (5%) patients died without being readmitted; 
346 (52%) had at least one unplanned readmission and 125 (19%) died after one or more further 
admissions.  
 Figure 2 
 Of patients who agreed to complete the psychosocial assessments, 35% had all 
assessments completed and 54% had at least 4 of them completed. Patients who had no events in 
the first year were younger, and were less likely to have a history of MI or COPD. (Table 1) 
 Patients with one or more follow up events were more likely to have moderate-to-severe 
depression or moderate-to-severe anxiety and were more likely to be frail; they were less likely 
to complete the “get up and go” test and were more likely to report difficulties in bathing or 
dressing. 
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 Table 1  
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3.2. All follow up 
 Figure 2b shows events for all 779 participants, including patients followed for less than 
one year and events that happened after the first year. Overall, 220 (28%) patients had no event; 
41 (5%) died without being readmitted; 518 (66%) had at least one unplanned readmission and 
228 (29%) died after one or more further admissions. 
 The incidence of unplanned readmission and mortality is shown in Figure 3, with a 
combined event rate of 70% [95% CI 68% - 72%] at one year.  
 Figure 3 
3.2.1. Risk factors for first event  
 There were 559 first events (41 deaths and 518 readmissions). Increasing age, a past 
history of MI or COPD, LVEF lower than 40%, and increasing urea and creatinine at discharge 
were all associated with increasing risk of first event. Amongst psychosocial variables, 
moderate-to-severe depression, moderate-to-severe anxiety, worsening cognitive impairment and 
the presence of frailty were all associated with adverse events. (Table 2a) 
3.2.2. Risk factors for recurrent events  
There was a total of 1600 events including 1041 events subsequent to the first. Increasing 
age, history of MI, the present of diabetes or COPD, and increasing urea and creatinine at 
discharge were all associated with increasing risk. Amongst psychosocial variables, moderate-to-
severe depression or anxiety, cognitive impairment and frailty, assessed by a question on 
troubles with bathing/dressing and/or by the ‘timed get up and go’ test, were all also associated 
with adverse events. Patients living alone also had a significantly higher risk (although not facing 
an increased risk of first event alone). (Table 2b) 
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 Table 2 
3.2.3. Impact of psychosocial factors adjusted for demographic and 
clinical variables 
In the statistical models adjusting for the clinical variables found to be significant in the 
univariable analysis (age, diabetes, history of MI, COPD, urea and creatinine), moderate-to-
severe depression, moderate-to-severe anxiety, cognitive impairment, the presence of frailty and 
living alone were significant predictors of adverse outcomes. (Table 3)  
Patients having troubles with bathing or dressing were 20% more likely to have one or 
more follow-up events compare to those not reporting troubles. Patients able to complete the “get 
up and go” test were 20% less likely to have a first follow up event than those who could not. 
Being unable to complete the test was a significant predictor of a first event, but not of recurrent 
events. Amongst those who did manage to complete the test, there was a 1% increase in risk of 
first or recurrent events for every extra second taken. 
 Table 3 
The impact of psychosocial variables on outcomes is plotted in Figure 4, with the patients 
grouped by having none or at least one of the following factors: moderate-to-severe depression; 
moderate-to-severe anxiety; cognitive impairment; more than 20 seconds needed to complete the 
‘get up and go’ test; troubles with bathing or dressing; or living alone.  
 Figure 4  
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4. Discussion 
Our study is one of the first to evaluate the impact of psychosocial factors on the risk of 
subsequent events in patients hospitalized for heart failure (HF). We found a high event rate, 
with 70% of patients being re-admitted or dying at one year follow up. In common with previous 
studies, we have found that older patients with more co-morbidities, or higher urea or creatinine, 
are more likely to have one or more unplanned events. We also found that the presence of frailty, 
anxiety and depression were powerful predictors of outcome, both of first and of recurrent 
events.  
We have previously reported that depression is strongly associated with increasing 
mortality in this cohort.5 In the present study, we have found that patients with moderate-to-
severe anxiety have a 1.7 times higher risk of a first event and a 1.4 higher risk of recurrent 
events compared to patients without anxiety. Patients with moderate-to-severe depression have a 
1.7 times higher risk of a first event and a 1.8 higher risk of recurrent events compared to 
patients without depression. Patients living alone or with cognitive impairment have a 1.2 and 
1.4 times higher risk of having multiple events after discharge compared to the patients not living 
alone or without cognitive impairment, respectively.  
Psychological factors such as depression,17,18 and other factors not directly related to the 
medical reason for an admission to hospital, such as cognitive impairment19 or frailty,20 are 
associated with adverse events in older people. We have found that these are also powerful 
predictors of adverse outcomes amongst patients hospitalized with HF. We also showed that the 
presence of at least one adverse psychosocial factor was associated with 1.8 higher risk of one or 
more recurrent events compared to having none.  
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Frailty is increasingly recognized as an important factor in managing patients with long 
term conditions,21 but although it is easily recognized clinically, it can be difficult to define. 
Increasing age is an obvious risk factor for frailty, and around a quarter of patients admitted to 
hospital for HF are over 80 years of age.22 Frailty is associated with poor nutritional status, itself 
associated with worse long-term outcome.23 There are recent studies concluding that an indicator 
of frailty in routine care is related to first readmission or mortality in HF patients7 or that amongst 
patients hospitalized for HF, worsening frailty measured by screening tools, such as the Derby 
frailty index (DFI) or clinical frailty scale (CFS), is strongly related to increasing mortality. 24 
The results of the present study show a strong association between the presence of frailty and the 
risk of follow up. Even the answer to a simple question about difficulties with daily activities has 
a similar predictive value as more elaborate screening tools. We also found that the ‘get up and 
go’ test, a simple test of mobility, is strongly related to outcome. For every extra second needed 
to complete the test the risk of recurrent events increased by 1%. As an indicator of “social 
frailty”, living alone was also associated with a worse outcome.  
Previous studies have not found an association between anxiety and mortality in HF 
although depression is associated with worse outcomes.4 We found that both depression and 
anxiety are related to the risk of recurrent events. The mechanism is not clear, but may be related 
to the reduced self-care seen amongst patients with depression.25 Further research is needed to 
see if any specific intervention targeted at psychological factors is helpful. Anti-depressant 
therapy in patient with HF does not affect mortality and morbidity 26 but psychotherapy in 
primary care has a limited beneficial effect on reducing depression in patients with a cardiac 
condition.27   
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Cognitive impairment is a risk factor for adverse events in patients with HF. 28 We found 
that cognitive impairment is also associated with an increased risk of recurrent post discharge 
events. Cognitive impairment is also an impediment to HF patients’ ability to self-care. 29  
We have thus found that a range of related conditions not directly associated with the HF 
syndrome itself – frailty (both physical and social), cognitive impairment, depression and anxiety 
– are all associated with an increased risk of adverse outcomes following discharge from hospital 
after an admission for HF. The individual patient should always be treated within his or her 
individual social context, and proper management should always consider whole patient, 
something of which it can be easy to lose sight in a busy hospital.  
It’s not clear from the present study whether targeted interventions for the conditions we 
have identified as predictors of a poor outcome might have a beneficial effect. Multidisciplinary 
interventions have shown some evidence of benefit,30 and exercise therapy can also help in frail 
subjects.31 Intervention trials are needed to see whether such interventions as providing extra 
help at home, day care or telemonitoring might be helpful. 
 
Limitations The Anderson-Gill approach assumes the recurrent events to be identically 
distributed and independent of each other, which might not always be the case. It also treats 
death as an event similar to readmission. Missing data is also a limitation in this study. However, 
there is evidence to support the method that we followed to impute part of the data. 15 Our 
analysis is based on patients hospitalized only in one location. Further external validation of the 
results is needed in order to support their generalizability.  
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Our methods have been developed for research and have not been extensively tested in 
routine practice for HF patients. The HADS survey will not give the same diagnostic certainty as 
ICD-9 or similar codes. The surveys were only administered once, and we may have missed 
changes during or after hospitalization or subsequent events. The questionnaires use some 
colloquial language which may not be understood by patients from different backgrounds.  
 
Conclusion. Moderate-to-severe depression and anxiety, living alone, cognitive 
impairment and the presence of frailty are strongly associated with unplanned recurrent 
admissions and mortality in the year following discharge after a HF admission to hospital. 
Studies are needed to show whether strategies to support patients from a social perspective and 
to target those with persistent problems with appropriate non-clinical interventions help to reduce 
risk.  
  
Page 17 of 32 
 
Funding and Conflict of interest  
Ioanna Sokoreli, Gert-Jan de Vries, Steffen Pauws, Jarno Riistama, Aleksandra Tesanovic are 
employed by Philips Research. John Cleland, Andrew Clark, Syed Kazmi, Pierpaolo Pellicori 
have received departmental research support from Philips. Ewout Steyerberg has no conflict of 
interest to declare.  
  
Page 18 of 32 
 
References 
1.  Cowie MR, Anker SD, Cleland JGF, Felker GM, Filippatos G, Jaarsma T, Jourdain P, 
Knight E, Massie B, Ponikowski P, López-Sendón J. Improving care for patients with 
acute heart failure: before, during and after hospitalization. ESC Hear Fail 2014;1:110–
145.  
2.  Ross JS, Mulvey GK, Stauffer B, Patlolla V, Bernheim SM, Keenan PS, Krumholz HM. 
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic 
Review. Arch Intern Med American Medical Association; 2008;168:1371.  
3.  Calvillo-King L, Arnold D, Eubank KJ, Lo M, Yunyongying P, Stieglitz H, Halm EA. 
Impact of social factors on risk of readmission or mortality in pneumonia and heart 
failure: Systematic review. J Gen Intern Med 2013;28:269–282.  
4.  Sokoreli I, Vries JJG de, Pauws SC, Steyerberg EW. Depression and anxiety as predictors 
of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail 
Rev 2016;21:49–63.  
5.  Sokoreli I, Vries JJG de, Riistama JM, Pauws SC, Steyerberg EW, Tesanovic A, Geleijnse 
G, Goode KM, Crundall-Goode A, Kazmi S, Cleland JG, Clark AL. Depression as an 
independent prognostic factor for all-cause mortality after a hospital admission for 
worsening heart failure. Int J Cardiol 2016;220:202–207.  
6.  Lupón J, González B, Santaeugenia S, Altimir S, Urrutia A, Más D, Díez C, Pascual T, 
Cano L, Valle V. Prognostic Implication of Frailty and Depressive Symptoms in an 
Outpatient Population With Heart Failure. Rev Española Cardiol (English Edition) 
2008;61:835–842.  
Page 19 of 32 
 
7.  Shao Y, Mohanty AF, Ahmed A, Weir CR, Bray BE, Shah RU, Redd D, Zeng-Treitler Q. 
Identification and Use of Frailty Indicators from Text to Examine Associations with 
Clinical Outcomes Among Patients with Heart Failure. AMIA . Annu Symp proceedings 
AMIA Symp 2016;2016:1110–1118.  
8.  Nikitin N., Witte KK., Thackray SD., Goodge L., Clark A., Cleland JG. Effect of Age and 
Sex on Left Atrial Morphology and Function. Eur Hear J - Cardiovasc Imaging 
2003;4:36–42.  
9.  Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JGF. The diagnostic utility of N-
terminal pro-B-type natriuretic peptide for the detection of major structural heart disease 
in patients with atrial fibrillation. Eur Heart J 2006;27:2353–2361.  
10.  Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr 
Scand 1983;67:361–370.  
11.  Brodaty H, Kemp NM, Low LF. Characteristics of the GPCOG, a screening tool for 
cognitive impairment. Int J Geriatr Psychiatry 2004;19:870–874.  
12.  Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the ‘get-up and go’ test. Arch 
Phys Med Rehabil 1986;67:387–389.  
13.  Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical 
trials: Good practice and pitfalls. Lancet 2002;359:1686–1689.  
14.  Andersen PK, Gill RD. Cox’s Regression Model for Counting Processes: A Large Sample 
Study. Ann Stat 1982;10:1100–1120.  
15.  Buuren S van. Flexible Imputation of Missing Data. CRC Press; 2012.  
Page 20 of 32 
 
16.  Rubin DB. Multiple Imputation for Nonresponse in Surveys. (Vol. 81). John Wiley & 
Sons.; 1987.  
17.  Schulz R, Drayer RA, Rollman BL. Depression as a risk factor for non-suicide mortality 
in the elderly. Biol Psychiatry 2002;52:205–225.  
18.  Penninx BWJH, Geerlings SW, Deeg DJH, Eijk JTM van, Tilburg W van, Beekman ATF. 
Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry; 
1999;56:889–895.  
19.  Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in the 
community-dwelling elderly. Am J Epidemiol 2000;151:676–688.  
20.  Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, 
Gardin JM. Risk factors for 5-year mortality in older adults: the Cardiovascular Health 
Study. JAMA 1998;279:585–592.  
21.  Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler 
WB, Harris T, Fried LP. Research Agenda for Frailty in Older Adults: Toward a Better 
Understanding of Physiology and Etiology: Summary from the American Geriatrics 
Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am 
Geriatr Soc 2006;54:991–1001.  
22.  Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, 
Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, 
Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L. EURObservational 
Research Programme: Regional differences and 1-year follow-up results of the Heart 
Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808–817.  
Page 21 of 32 
 
23.  Al-Najjar Y, Clark AL. Predicting Outcome in Patients With Left Ventricular Systolic 
Chronic Heart Failure Using a Nutritional Risk Index. Am J Cardiol 2012;109:1315–1320.  
24.  Sze S, Zhang J, Pellicori P, Morgan D, Hoye A, Clark AL. Prognostic value of simple 
frailty and malnutrition screening tools in patients with acute heart failure due to left 
ventricular systolic dysfunction. Clin Res Cardiol 2017;106:533–541.  
25.  Widdershoven J, Kessing D, Schiffer A, Denollet J, Kupper N. How are depression and 
Type D personality associated with outcomes in chronic heart failure patients? Curr Heart 
Fail Rep 2013;10:244–253.  
26.  O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, 
Stough WG, Arias RM, Rivelli SK, Krishnan R. Safety and efficacy of sertraline for 
depression in patients with heart failure: Results of the SADHART-CHF (Sertraline 
against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol 
2010;56:692–699.  
27.  Coventry P, Lovell K, Dickens C, Bower P, Chew-Graham C, McElvenny D, Hann M, 
Cherrington A, Garrett C, Gibbons CJ, Baguley C, Roughley K, Adeyemi I, Reeves D, 
Waheed W, Gask L. Integrated primary care for patients with mental and physical 
multimorbidity: cluster randomised controlled trial of collaborative care for patients with 
depression comorbid with diabetes or cardiovascular disease. Bmj 2015;350:h638–h638.  
28.  Vogels RLC, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in 
heart failure: A systematic review of the literature. Eur J Heart Fail 2007;9:440–449.  
29.  Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive 
impairment predict poor self-care in patients with heart failure? Eur J Heart Fail 
Page 22 of 32 
 
2010;12:508–515.  
30.  Cameron ID, Fairhall N, Langron C, Lockwood K, Monaghan N, Aggar C, Sherrington C, 
Lord SR, Kurrle SE. A multifactorial interdisciplinary intervention reduces frailty in older 
people: randomized trial. BMC Med 2013;11:65.  
31.  Vries NM de, Ravensberg CD van, Hobbelen JSM, Olde Rikkert MGM, Staal JB, Nijhuis-
van der Sanden MWG. Effects of physical exercise therapy on mobility, physical 
functioning, physical activity and quality of life in community-dwelling older adults with 
impaired mobility, physical disability and/or multi-morbidity: A meta-analysis. Ageing 
Res Rev 2012;11:136–149.  
  
Page 23 of 32 
 
Figure legends 
Figure 1 Consort Diagram .......................................................................................................................... 29 
Figure 2 (a) Diagram of events within first year of discharge, based on 671 patients surviving to index-
admission discharge and with known outcome  at one year; (b) Diagram of all events for 779 patients 
discharged after the index-admission  (including those not censored at one year). .................................... 30 
Figure 3 Cumulative incidence plot of events; recurrent readmissions and mortality. For the plot gap 
times are used. That means that every recurrent event of a patient is taken into account as a new sample 
for the calculations starting from point zero. Dotted grey lines: incidence rate at 1 year; Dotted black 
lines: 95% confidence interval. ................................................................................................................... 31 
Figure 4 Cumulative incidence plot of events (recurrent readmissions and mortality) of patients having at 
least one psychosocial factor assessed negatively compared to those with none, adjusted for significant 
demographic and clinical factors. We used data of the 477 patents who had participated to at least one of 
the psychosocial assessments. ..................................................................................................................... 32 
24 
 
Tables 
Table 1 Baseline characteristics for all study participants and all participants with follow up at one year 
stratified by number and type of events. Characteristics are summarized by their count and fraction (N (%)) 
for categorical or their median and interquartile range (Median [25th – 75th]) for continuous variables 
respectively; (*) null hypothesis: no significant difference between those with no event and those with at least 
one event; readmission(s) and/or death within one year, 0.1 level of significance; (**) NYHA class which was 
evaluated as the worst class during the last 7-days before admission; (***) the closest measurement to 
discharge. N# = number of patients with this variable available. 
 All patient data Patients with one year follow-up data 
Event All 
 
(N = 779) 
All Patients 
 
(N = 671) 
No Events 
 
(N = 291) 
One re-
admission 
(N=121) 
Death/ No 
re-admission 
(N = 34) 
>1 event 
 
(N = 225) 
Compari
son 
Characteristics N#  N#      P-value* 
Women % 779 271 (35 %) 671 230 (34 %) 109 (37 %) 47 (39 %) 7 (21 %) 67 (30 %) 0.15 
Age years 779 75 [67-82] 671 76 [67 -82] 73 [64-80] 75 [68-81] 79 [73-86] 78 [71-84] <0.01 
Diabetes % 779 278 (36 %) 671 243 (36 %) 101 (35 %) 45 (37 %) 14 (48 %) 83 (37 %) 0.53 
History of MI % 779 183 (23 %) 671 163 (24 %) 57 (20 %) 34 (28 %) 12 (35 %) 60 (27 %) <0.05 
COPD % 779 136 (17 %) 671 111 (17 %) 35 (12 %) 21 (17 %) 7 (21 %) 48 (21 %) <0.01 
Cancer % 779 69 (10 %) 671 72 (10 %) 31 (11 %) 16 (13 %) 2 (6 %) 20 (9 %) 0.88 
NYHA **: 
Class I/II %  
 NYHA: Class III %  
 NYHA: Class IV % 
672  
68 (10 %) 
427 (64 %)  
177 (26 %) 
569  
67 (12 %)  
365 (64 %)  
137 (24 %) 
 
29 (12 %)  
163 (67%)  
52 (21 %) 
 
14 (14 %)  
70 (71 %)  
15 (15 %) 
 
0 (0 %)  
20 (74 %)  
7 (26 %) 
 
24 (12 %)  
112 (56 %)  
63 (32 %) 
 
0.61 
Hypertension at ADM % 726 359 (58 %) 622 359 (58 %) 163 (59 %) 64 (55 %) 17 (55 %) 115 (57 %) 0.48 
NT-proBNP pg/mL *** 664 4300[1803 
– 9456] 
570 4599[1934 -
9553] 
3931[1894 
– 7954] 
4280[1576-
9023] 
6369[3884-
16657] 
5414[2083 
-10843] 
0.46 
Sinus rhythm at DIS % 779 286 (37 %) 671 250 (37 %) 115 (40 %) 39 (32 %) 12 (35 %) 84 (37 %) 0.33 
LVEF at DIS ≤ 40 % 683 286 (42 %) 588 241 (41 %) 95 (37 %) 51 (47 %) 13 (45 %) 82 (42 %) 0.11 
Main presentation:  
-Severe peripheral oedema %  
-Severe breathlessness at rest%  
768  
59 (8 %)  
225 (29 %)  
660  
50 (8 %)  
204 (31 %)  
 
20 (7 %)  
94 (34 %)  
 
6 (5 %)  
36 (30 %)  
 
5 (16 %)  
8 (25 %)  
 
19 (9 %)  
64 (29 %)  
0.48 
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-Increasing exertional 
breathlessness % 
-Chest pain-cardiac %  
-Other symptom % 
 
356 (46 %)  
72 (9 %)  
56 (7 %) 
 
285 (43 %) 
67 (10 %)  
54 (8 %) 
 
115 (40 %)  
28 (10 %)  
24 (9 %) 
 
53 (44 %)  
16 (13 %)  
10 (8 %) 
 
17 (53 %)  
2 (6 %)  
0 (0 %) 
 
100 (45 %)  
21 (9 %)  
17 (8 %) 
Urea at DIS mmol/L 776 9 [7 - 14] 669 9 [6 - 14] 8 [6 - 11] 9 [6 - 14] 18 [11 - 25] 11 [8 - 15] 0.17 
Creatinine at DIS µmol/L 774 106 
[84-141] 
668 106 
[84-143] 
97  
[80-125] 
104  
[86-141] 
161 
[111 -210] 
119  
[91 - 157] 
0.26 
Depression HADS  
 -None-to-mild %  
 -Moderate-to-severe % 
371  
316 (85 %)  
55 (15 %) 
300  
255 (85 %)  
45 (15 %) 
 
122 (91%)  
12 (9 %) 
 
44 (83 %)  
9 (17 %) 
 
13 (81 %)  
3 (19 %) 
 
76 (78 %)  
21 (22 %) 
<0.05 
Anxiety HADS  
 -None-to-Mild %  
 -Moderate-to-severe % 
366  
300 (82 %)  
66 (18 %) 
296  
243 (82 %) 
 53 (18 %) 
 
120 (89 %)  
15 (11 %) 
 
35 (70 %) 
 15 (30 %) 
 
14 (87 %)  
2 (13 %) 
 
74 (78 %)  
21 (22 %) 
<0.01 
GPCOG score ≤ 4 % 380 28 (7 %) 315 25 (8 %) 7 (5 %) 2 (4 %) 3 (18 %) 13 (13 %) 0.11 
Living alone % 660 218 (33 %) 566 184 (33 %) 74 (30 %) 32 (30 %) 9 (36 %) 69 (33 %) 0.29 
Trouble bathing/dressing % 644 157 (24 %) 553 134 (24 %) 46 (19 %) 24 (23 %) 10 (42 %) 54 (30 %) <0.05 
Get up and go test:  
-Able to complete % 
 
614 
 
285 (46 %) 
 
520 
 
242 (46 %) 
 
116 (51 %) 
 
40 (42 %) 
 
7 (29 %) 
 
79 (45 %) 
 
<0.1 
Time to complete sec 285 9 [6 - 15] 242 10 [6 - 16] 8 [6 - 12] 11 [8 - 20] 15 [4 - 22] 12 [8 - 20] 0.14 
MI Myocardial infarction; NYHA New York Heart Association; ADM admission; DIS discharge; LVEF left ventricular ejection fraction; HADS Hospital 
Anxiety and Depression Scale; GPCOG General Practitioner assessment of Cognition. 
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Table 2 (a) Univariable Cox regression model for first unplanned readmission or death (b) Univariable 
Anderson-Gill model for recurrent events. (*) 0.1 level of significance; (**) NYHA class which was evaluated 
as the worst class during the last 7-days before admission; (***) the closest measurement to discharge. 
 (a) First event only (b) Recurrent events  
 (N*/events) HR  95% CI P-value* (N / events) HR  95% CI P-value* 
Women yes (779 / 559) 0.97 0.82 - 1.15 0.70 (2110 / 1600) 1.06 0.88 - 1.27 0.53 
Age years 
(10 unit increase) 
(779 / 559) 1.24 1.15 – 1.35 <0.001 (2110 / 1600) 1.29 1.16 – 1.43 <0.001 
Diabetes yes (779 / 559) 1.10 0.93 – 1.30 0.28 (2110 / 1600) 1.34 1.12 – 1.59 <0.001 
History of MI yes (779 / 559) 1.29 1.07 – 1.55 <0.01 (2110 / 1600) 1.33 1.10 – 1.62 <0.01 
COPD yes (779 / 559) 1.43 1.14 – 1.79 <0.01 (2110 / 1600) 1.50 1.20 – 1.89 <0.001 
Cancer yes (779 / 559) 0.97 0.74 – 1.27 0.83 (2110 / 1600) 1.04 0.78 – 1.40 0.77 
NYHA **: Class I or II yes 
NYHA: Class III yes 
NYHA: Class IV yes 
(672 / 468) 1 
1.05 
1.19 
- 
0.76 – 1.44 
0.85 – 1.68 
- 
0.77 
0.31 
(1785 / 1343) 1 
1.10 
1.29 
- 
0.81 – 1.49 
0.92 – 1.81 
- 
0.53 
0.14 
Hypertension at ADM yes (726 / 515) 1.03 0.86 - 1.23 0.73 (1957 / 1477) 1.04 0.86 - 1.25 0.70 
Log(NT-proBNP) pg/mL *** (664 / 477) 1.05 0.98 – 1.14 0.17 (1833 / 1396) 1.02 0.96 – 1.12 0.32 
Sinus Rhythm at DIS yes (779 / 559) 0.91 0.76 - 1.08 0.28 (2110 / 1600) 0.95 0.79 – 1.13 0.57 
LVEF at discharge: ≤40% yes (683 / 479) 1.20 1.00 – 1.44 <0.05 (1845 / 1395) 1.17 0.97 – 1.41  0.10 
Main presentation:  
-Severe peripheral oedema yes 
-Severe breathlessness at rest yes -
Increasing exertional 
breathlessness yes 
-Chest pain - cardiac yes 
-Other symptom yes 
(768 / 548)  
1 
0.94 
1.07 
 
1.11 
1.06 
 
- 
0.64 – 1.38 
0.74 – 1.56 
 
0.72 – 1.70 
0.68 – 1.64 
 
- 
0.74 
0.71 
 
0.64 
0.81 
(2076 / 1571)  
1 
0.84 
1.02 
 
1.00 
0.92 
 
- 
0.59 – 1.20 
0.73 – 1.45 
 
0.65 – 1.53 
0.61 – 1.37 
 
- 
0.35 
0.89 
 
1.00 
0.67 
Urea at discharge mmol/L  
(10 unit increase)  
(776 / 557) 1.27 1.15 – 1.40 <0.001 (2099 / 1590)  1.25 1.15 – 1.36 <0.001 
Creatinine at discharge µmol/L (774 / 556) 1.54 1.38 – 1.72 <0.001 (2094 / 1587)  1.54 1.39 – 1.72 <0.001 
Depression HADS  
-None-to-mild yes 
-Moderate-to-severe yes 
(371 / 227)  
1.00 
1.73 
 
– 
1.24 – 2.41 
 
– 
<0.01 
(866 / 596)  
1.00 
1.76 
 
– 
1.25 - 2.47 
 
– 
<0.001 
Anxiety HADS  (366 / 222)    (848 / 581)    
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-None-to-mild yes 
-Moderate-to-severe yes 
1.00 
1.64 
– 
1.24 – 2.18 
– 
<0.001 
1.00 
1.37 
– 
1.03 - 1.84 
– 
<0.05 
GPCOG score ≤ 4 yes (380 / 232)  1.70 1.06 – 2.71 <0.05 (903 / 628) 1.58 1.00 – 2.50 <0.1 
Living alone yes (660 / 465) 1.14 0.94 - 1.39 0.18 (1781 / 1341) 1.37 1.12 – 1.67 <0.01 
Trouble bathing or dressing yes (644 / 453) 1.48 1.20 – 1.83 <0.001 (1736 / 1303) 1.27 1.02 – 1.57 <0.05 
Get up and go test: 
-Able to complete yes 
 
(614 / 421) 
 
0.72 
 
0.59 – 0.87 
 
<0.001 
 
(1646 / 1229) 
 
0.81 
 
0.66 – 0.99 
 
<0.05 
-Time to complete sec (285 / 169) 1.02 1.01 – 1.03 <0.001 (701 / 495) 1.02 1.01 – 1.03  <0.001 
HR Hazard Ratio; CI Confidence Interval NYHA New York Heart Association; LVEF left ventricular ejection fraction; HADS Hospital Anxiety 
and Depression Scale; GPCOG General Practitioner assessment of Cognition. 
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Table 3 (a) Adjusted Cox regression model for first unplanned readmission or death (b) Adjusted Anderson-
Gill model for recurrent events. (*) 0.1 level of significance; (**) each variable is adjusted for the most 
significant (P<0.01) clinical variables including age, diabetes, history of MI, COPD, urea and creatinine at 
discharge (see Table 2). 
 (a) First event only ** (b) Recurrent events ** 
 
 HR  95% CI P-value * HR  95% CI P-value * 
Depression HADS  
-None-to-mild yes 
-Moderate-to-severe yes 
 
1.00 
1.74 
 
– 
1.24 - 2.44 
 
– 
<0.01 
 
1.00 
1.77 
 
– 
1.44 - 2.17 
 
– 
<0.001 
Anxiety HADS  
-None-to-mild yes 
-Moderate-to-severe yes 
 
1.00 
1.67 
 
– 
1.21 - 2.30 
 
– 
<0.01 
 
1.00 
1.35 
 
– 
1.11 - 1.65 
 
– 
<0.01 
GPCOG score ≤ 4 yes 1.43 0.90 – 2.28 0.12 1.40 1.06 – 1.85 <0.05 
Living alone yes 1.04 0.85 – 1.27 0.71 1.24 1.11 – 1.39 <0.001 
Trouble bathing or dressing yes 1.33 1.07 – 1.65 <0.01 1.18 1.04 – 1.35 <0.05 
Get up and go test: 
-Able to complete yes 
 
0.81 
 
0.66 – 0.99 
 
<0.05 
 
0.95 
 
0.84 – 1.07 
 
0.38 
-Time to complete sec 1.02 1.01 – 1.03 <0.01 1.01 1.01 – 1.02 <0.001 
HR Hazard Ratio; CI Confidence Interval; HADS Hospital Anxiety and Depression Scale; GPCOG General Practitioner assessment of Cognition. 
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Figure 2 (a) Diagram of events within first year of discharge, based on 671 patients surviving to index-admission 
discharge and with known outcome  at one year; (b) Diagram of all events for 779 patients discharged after the index-
admission  (including those not censored at one year). 
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Figure 3 Cumulative incidence plot of events; recurrent readmissions and mortality. For the plot gap times are used. That 
means that every recurrent event of a patient is taken into account as a new sample for the calculations starting from 
point zero. Dotted grey lines: incidence rate at 1 year; Dotted black lines: 95% confidence interval. 
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Figure 4 Cumulative incidence plot of events (recurrent readmissions and mortality) of patients having at least one 
psychosocial factor assessed negatively compared to those with none, adjusted for significant demographic and clinical 
factors. We used data of the 477 patents who had participated to at least one of the psychosocial assessments. 
